In this video from the American Academy of Ophthalmology meeting, Philip J. Ferrone, MD, discusses the TEASE-2 trial results in treating Stargardt disease with gildeuretinol.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback